JP2016513090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016513090A5 JP2016513090A5 JP2015556243A JP2015556243A JP2016513090A5 JP 2016513090 A5 JP2016513090 A5 JP 2016513090A5 JP 2015556243 A JP2015556243 A JP 2015556243A JP 2015556243 A JP2015556243 A JP 2015556243A JP 2016513090 A5 JP2016513090 A5 JP 2016513090A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- nanoparticles
- nanoparticle
- core
- medically useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361761012P | 2013-02-05 | 2013-02-05 | |
| US61/761,012 | 2013-02-05 | ||
| PCT/US2014/014751 WO2014123935A1 (en) | 2013-02-05 | 2014-02-05 | Biodegradable and clinically-compatible nanop articles as drug delivery carriers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016513090A JP2016513090A (ja) | 2016-05-12 |
| JP2016513090A5 true JP2016513090A5 (enExample) | 2017-03-02 |
| JP6507102B2 JP6507102B2 (ja) | 2019-04-24 |
Family
ID=51300093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556243A Active JP6507102B2 (ja) | 2013-02-05 | 2014-02-05 | 薬物送達キャリアとしての生分解性でかつ臨床上適合性のナノ粒子 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11001840B2 (enExample) |
| EP (2) | EP3845248A1 (enExample) |
| JP (1) | JP6507102B2 (enExample) |
| KR (1) | KR20150132131A (enExample) |
| AU (2) | AU2014215421A1 (enExample) |
| CA (1) | CA2899155A1 (enExample) |
| ES (1) | ES2873600T3 (enExample) |
| IL (1) | IL240148A0 (enExample) |
| MX (1) | MX2015010083A (enExample) |
| RU (1) | RU2015137815A (enExample) |
| SG (2) | SG11201506116XA (enExample) |
| WO (1) | WO2014123935A1 (enExample) |
| ZA (1) | ZA201506530B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014123935A1 (en) | 2013-02-05 | 2014-08-14 | 1Globe Health Institute Llc | Biodegradable and clinically-compatible nanop articles as drug delivery carriers |
| KR20160042917A (ko) | 2013-07-25 | 2016-04-20 | 엑시큐어, 인크. | 예방 및 치료 용도를 위한 면역자극제로서의 구형 핵산-기재 구축물 |
| EP3164113B1 (en) | 2014-06-04 | 2019-03-27 | Exicure, Inc. | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications |
| WO2016028940A1 (en) | 2014-08-19 | 2016-02-25 | Northwestern University | Protein/oligonucleotide core-shell nanoparticle therapeutics |
| US11213593B2 (en) | 2014-11-21 | 2022-01-04 | Northwestern University | Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| KR20170104550A (ko) * | 2015-01-14 | 2017-09-15 | 엑시큐어, 인크. | 코어 모티프를 갖는 핵산 나노구조 |
| JP7186094B2 (ja) | 2016-05-06 | 2022-12-08 | イグジキュア オペレーティング カンパニー | インターロイキン１７受容体ｍＲＮＡの特異的ノックダウンのためのアンチセンスオリゴヌクレオチド（ＡＳＯ）を提示するリポソーム系球状核酸（ＳＮＡ）構築物 |
| US11364304B2 (en) | 2016-08-25 | 2022-06-21 | Northwestern University | Crosslinked micellar spherical nucleic acids |
| WO2018098352A2 (en) | 2016-11-22 | 2018-05-31 | Jun Oishi | Targeting kras induced immune checkpoint expression |
| US10800817B2 (en) | 2016-12-19 | 2020-10-13 | Morehouse School Of Medicine | Compositions and methods for treating diseases by inhibiting exosome release |
| PL3568122T3 (pl) * | 2017-01-10 | 2024-03-18 | Dukebox Sp. Z O.O. | Sposób wytwarzania zawiesiny nanocząsteczek soli potasowej albo soli magnezowej |
| US11696954B2 (en) | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| KR102120482B1 (ko) * | 2018-10-05 | 2020-06-08 | 씨제이제일제당 (주) | 생분해성 고분자 나노입자를 포함하는 메모리 소자 및 이의 제조방법 |
| EP3996751A1 (en) * | 2019-07-12 | 2022-05-18 | The Board Of Trustees Of The Leland Stanford Junior University | Functionalized nanoparticles and their use in treating bacterial infections |
| US20240050369A1 (en) * | 2019-10-04 | 2024-02-15 | The University Of Chicago | Targeted Nanomedicine for Treating Vascular Disorders |
| US20230070049A1 (en) * | 2020-02-03 | 2023-03-09 | Rutgers, The State University Of New Jersey | Microrna-7 compositions for promoting functional recovery following spinal cord injury and methods of use thereof |
| US11998615B2 (en) | 2021-04-14 | 2024-06-04 | The Board Of Trustees Of The Leland Stanford Junior University | Functionalized nanoparticles and their use in treating bacterial infections |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5219577A (en) | 1990-06-22 | 1993-06-15 | The Regents Of The University Of California | Biologically active composition having a nanocrystalline core |
| TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
| US5879715A (en) * | 1997-09-02 | 1999-03-09 | Ceramem Corporation | Process and system for production of inorganic nanoparticles |
| DE19856432A1 (de) * | 1998-12-08 | 2000-06-15 | Basf Ag | Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen |
| DE19912502A1 (de) | 1999-03-19 | 2000-09-21 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung |
| JP2004511572A (ja) | 2000-10-25 | 2004-04-15 | ザ ユニバーシティ オブ ブリティッシュ コロンビア | 標的化送達のための脂質製剤 |
| IN192520B (enExample) * | 2001-08-01 | 2004-04-24 | Univ Delhi | |
| SG190613A1 (en) | 2003-07-16 | 2013-06-28 | Protiva Biotherapeutics Inc | Lipid encapsulated interfering rna |
| US7651694B2 (en) | 2004-02-13 | 2010-01-26 | Nod Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of making and using same |
| US7611690B2 (en) | 2005-01-04 | 2009-11-03 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
| US20110081410A1 (en) | 2005-06-28 | 2011-04-07 | St. Marianna University, School Ofmedicine | Therapeutic agent for local inflammation |
| CN100435784C (zh) * | 2005-07-25 | 2008-11-26 | 管晓虹 | 含有和包封中药成分的无机盐纳米粒子的制备方法 |
| WO2008045806A2 (en) * | 2006-10-06 | 2008-04-17 | Microislet, Inc. | Multilayered polyelectrolyte-based capsules for cell encapsulation and delivery of therapeutic compositions |
| CA2682135A1 (en) | 2007-04-17 | 2008-10-30 | Baxter International Inc. | Nucleic acid microparticles for pulmonary delivery |
| US20110038939A1 (en) * | 2007-07-16 | 2011-02-17 | Northeastern University | Therapeutic stable nanoparticles |
| EP2193140B1 (en) | 2007-08-27 | 2016-11-02 | 1Globe Health Institute LLC | Compositions of asymmetric interfering rna and uses thereof |
| EP2197454A4 (en) | 2007-09-25 | 2012-07-04 | Idexx Lab Inc | PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF OLIGONUCLEOTIDES |
| EP2241314B1 (en) | 2007-12-14 | 2013-04-17 | Ezaki Glico Co., Ltd. | Alpha-lipoic acid nanoparticle and method for producing the same |
| CA2710983A1 (en) | 2007-12-27 | 2009-10-01 | The Ohio State University Research Foundation | Lipid nanoparticle compositions and methods of making and using the same |
| CN102065902A (zh) | 2008-05-13 | 2011-05-18 | 华盛顿大学 | 聚合物载体 |
| EP2421880A4 (en) | 2008-11-26 | 2012-11-28 | Univ Kansas | COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF NUCLEIC ACID |
| ATE544472T1 (de) * | 2008-12-19 | 2012-02-15 | Biolitec Ag | Kalziumphosphat-nanopartikel als farbstoffträger für die photodynamische therapie |
| US9937128B2 (en) * | 2009-08-03 | 2018-04-10 | The University Of North Carolina At Chapel Hill | Liposomes comprising a calcium phosphate-containing precipitate |
| WO2011030946A1 (ko) * | 2009-09-14 | 2011-03-17 | 주식회사 나노하이브리드 | 표적지향성 sirna-층상형 무기 수산화물 나노혼성체, 그 제조방법, 및 나노혼성체를 함유하는 종양 치료용 약학 조성물 |
| JP5491119B2 (ja) * | 2009-10-02 | 2014-05-14 | 日東電工株式会社 | 薬物含有微粒子を含む医薬組成物およびその製造方法 |
| WO2011140024A2 (en) * | 2010-05-03 | 2011-11-10 | University Of Utah Research Foundation | Nanoparticles produced from recombinant polymers and methods of making and using the same |
| WO2013040295A2 (en) * | 2011-09-14 | 2013-03-21 | University Of South Florida | Divalent-metal coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation |
| ES2721325T3 (es) | 2011-11-04 | 2019-07-31 | Nitto Denko Corp | Método para producir de manera estéril partículas de lípido-ácido nucleico |
| US20130243699A1 (en) * | 2011-12-07 | 2013-09-19 | Regents Of The University Of Minnesota | Biodegradable Magnetic Nanoparticles and Related Methods |
| ITRM20120480A1 (it) | 2012-10-09 | 2014-04-10 | Uni Degli Studi Camerino | Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione. |
| WO2014123935A1 (en) | 2013-02-05 | 2014-08-14 | 1Globe Health Institute Llc | Biodegradable and clinically-compatible nanop articles as drug delivery carriers |
-
2014
- 2014-02-05 WO PCT/US2014/014751 patent/WO2014123935A1/en not_active Ceased
- 2014-02-05 RU RU2015137815A patent/RU2015137815A/ru not_active Application Discontinuation
- 2014-02-05 MX MX2015010083A patent/MX2015010083A/es unknown
- 2014-02-05 CA CA2899155A patent/CA2899155A1/en not_active Abandoned
- 2014-02-05 EP EP20204049.9A patent/EP3845248A1/en active Pending
- 2014-02-05 JP JP2015556243A patent/JP6507102B2/ja active Active
- 2014-02-05 SG SG11201506116XA patent/SG11201506116XA/en unknown
- 2014-02-05 ES ES14748796T patent/ES2873600T3/es active Active
- 2014-02-05 AU AU2014215421A patent/AU2014215421A1/en not_active Abandoned
- 2014-02-05 SG SG10201706968UA patent/SG10201706968UA/en unknown
- 2014-02-05 KR KR1020157024176A patent/KR20150132131A/ko not_active Withdrawn
- 2014-02-05 EP EP14748796.1A patent/EP2953646B1/en active Active
- 2014-02-05 US US14/765,763 patent/US11001840B2/en active Active
-
2015
- 2015-07-26 IL IL240148A patent/IL240148A0/en unknown
- 2015-09-04 ZA ZA2015/06530A patent/ZA201506530B/en unknown
-
2018
- 2018-02-07 AU AU2018200903A patent/AU2018200903A1/en not_active Abandoned
-
2021
- 2021-04-06 US US17/223,647 patent/US20210230595A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015137815A (ru) | Биодеградируемые и клинически совместимые наночастицы в качестве носителей для доставки лекарственного средства | |
| Lim et al. | Polymeric nanoparticles in development for treatment of pulmonary infectious diseases | |
| CN106793970B (zh) | 用于诊断及治疗的纳米载剂及其加工 | |
| Zhao et al. | Dual-functional lipid polymeric hybrid pH-responsive nanoparticles decorated with cell penetrating peptide and folate for therapy against rheumatoid arthritis | |
| KR101243689B1 (ko) | 미립자 및 의약품 조성물 | |
| Bassyouni et al. | Advances and new technologies applied in controlled drug delivery system | |
| US11850309B2 (en) | Cationic materials and formulations for drug delivery | |
| CN103040724B (zh) | 含聚合物与磷脂的纳米载药系统及其制备方法 | |
| Cheng et al. | Cell-mediated nanoparticle delivery systems: towards precision nanomedicine | |
| He et al. | Recent development of poly (ethylene glycol)-cholesterol conjugates as drug delivery systems | |
| KR20140138639A (ko) | 점막 침투 강화를 나타내는 나노 입자 제형 | |
| US20220175953A1 (en) | Biomimetic anisotropic polymeric particles with naturally derived cell membranes for enhanced drug delivery | |
| Wang et al. | Advanced hitchhiking nanomaterials for biomedical applications | |
| Liu et al. | Use of nanoformulation to target macrophages for disease treatment | |
| AU2020205473B2 (en) | Polymersomes functionalised with multiple ligands | |
| KR20140084144A (ko) | 출혈 제어 및 약물 전달을 위한 나노입자 | |
| KR100792557B1 (ko) | 나노 캡슐화를 이용하여 제조된 지질 핵 및 고분자 쉘구조를 갖는 단백질 약물 전달용 나노 미립구 | |
| Naghib et al. | Stimuli-sensitive chitosan-based nanosystems-immobilized nucleic acids for gene therapy in breast cancer and hepatocellular carcinoma | |
| Shi et al. | Advances in nanotherapy for targeting senescent cells | |
| Chinnagounder Periyasamy et al. | Nanomaterials for the local and targeted delivery of osteoarthritis drugs | |
| CN111107842A (zh) | 利用微混合和卡培他滨两亲性特性的卡培他滨的聚合物-脂质混杂纳米颗粒 | |
| CN107519496B (zh) | 一类l-肉毒碱两亲性衍生物及其修饰的纳米粒及其用途 | |
| Ulku et al. | The importance of nanotechnology and drug carrier systems in pharmacology | |
| Barbosa et al. | Nanotechnology applied in drug delivery | |
| Liu et al. | Aptamer-based drug delivery systems |